Cellular cardiac regenerative therapy in which patients?

References

• Bartunek J, Sherman W, Vanderheyden M, Fernandez-Aviles F, Wijns W, Terzic A. Delivery of biologics in cardiovascular regenerative medicine. Clin. Pharmacol. Ther.85, 548–552 (2009).
   PubMed Web of Science ®Google Scholar
• Reffelmann T, Könemann S, Kloner RA. Promise of blood- and bone marrow-derived stem cell transplantation for functional cardiac repair: putting it in perspective with existing therapy. J. Am. Coll. Cardiol.53, 305–308(2009).
   PubMed Web of Science ®Google Scholar
• Genovese J, Cortes-Morichetti M, Chachques E, Frati G, Patel A, Chachques JC. Cell based approaches for myocardial regeneration and artificial myocardium. Curr. Stem Cell Res. Ther.2, 121–127 (2007).
   PubMedGoogle Scholar
• van den Borne SW, Isobe S, Verjans JW et al. Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction. J. Am. Coll. Cardiol.52, 2017–2028 (2008).
   PubMed Web of Science ®Google Scholar
• Fernández-Avilés F, San Román JA, García-Frade J et al. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ. Res.95, 742–748 (2004).
   PubMed Web of Science ®Google Scholar
• Bergmann O, Bhardwaj RD, Bernard S et al. Evidence for cardiomyocyte renewal in humans. Science324, 98–102 (2009).
   PubMed Web of Science ®Google Scholar
• Chachques JC, Acar C, Herreros J, Trainini JC, Fabiani JN, Carpentier AF. Cellular cardiomyoplasty: clinical application. Ann. Thorac. Surg.77, 1121–1130 (2004).
   PubMed Web of Science ®Google Scholar
• Bartunek J, Dimmeler S, Drexler H et al.; Task Force of the European Society of Cardiology. The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heart. Eur. Heart J.27, 1338–1340 (2006).
   PubMed Web of Science ®Google Scholar
• Lipinski MJ, Biondi-Zoccai GG, Abbate A et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J. Am. Coll. Cardiol.50, 1761–1767 (2007).
   PubMed Web of Science ®Google Scholar
• Tendera M, Wojakowski W, Ruzyllo W et al.; REGENT Investigators. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur. Heart J.30(11), 1313–1321 (2009).
   PubMed Web of Science ®Google Scholar
• Rajnoch C, Chachques JC, Berrebi A, Bruneval P, Benoit MO, Carpentier A. Cellular therapy reverses myocardial dysfunction. J. Thorac. Cardiovasc. Surg.121, 871–878 (2001).
   PubMed Web of Science ®Google Scholar
• Elmadbouh I, Michel JB, Chachques JC. Mesothelial cell transplantation in myocardial infarction. Int. J. Artif. Organs30, 541–549 (2007).
   PubMed Web of Science ®Google Scholar
• Musina RA, Belyavski AV, Tarusova OV, Solovyova EV, Sukhikh GT. Endometrial mesenchymal stem cells isolated from the menstrual blood. Bull. Exp. Biol. Med.145, 539–543 (2008).
   PubMed Web of Science ®Google Scholar
• Patel AN, Park E, Kuzman M, Benetti F, Silva FJ, Allickson JG. Multipotent menstrual blood stromal stem cells: isolation, characterization, and differentiation. Cell Transplant.17, 303–311 (2008).
   PubMed Web of Science ®Google Scholar
• Hida N, Nishiyama N, Miyoshi S et al. Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells. Stem Cells26, 1695–1704 (2008).
   PubMed Web of Science ®Google Scholar
• Conrad S, Renninger M, Hennenlotter J et al. Generation of pluripotent stem cells from adult human testis. Nature456, 344–349 (2008).
   PubMed Web of Science ®Google Scholar
• Zhou B, Ma Q, Rajagopal S et al. Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature454, 109–113 (2008).
   PubMed Web of Science ®Google Scholar
• Chachques JC, Salanson-Lajos C, Lajos P, Shafy A, Alshamry A, Carpentier A. Cellular cardiomyoplasty for myocardial regeneration. Asian Cardiovasc. Thorac. Ann.13, 287–296 (2005).
   PubMedGoogle Scholar
• Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res.103, 1204–1219 (2008).
   PubMed Web of Science ®Google Scholar
• Perez-Ilzarbe M, Agbulut O, Pelacho B et al. Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium. Eur. J. Heart Fail.10, 1065–1072 (2008).
   PubMed Web of Science ®Google Scholar
• Fedak PW, Szmitko PE, Weisel RD et al. Cell transplantation preserves matrix homeostasis: a novel paracrine mechanism. J. Thorac. Cardiovasc. Surg.130, 1430–1439 (2005).
   PubMed Web of Science ®Google Scholar
• Belanger AR, Miller MA, Donthireddi UR, Najovits AJ, Goldman ME. New classification scheme of left ventricular noncompaction and correlation with ventricular performance. Am. J. Cardiol.102, 92–96 (2008).
   PubMed Web of Science ®Google Scholar
• Fernandes S, Amirault JC, Lande G et al. Autologous myoblast transplantation after myocardial infarction increases the inducibility of ventricular arrhythmias. Cardiovasc. Res.69, 348–358 (2006).
   PubMed Web of Science ®Google Scholar
• Villa A, Sanchez PL, Fernandez-Aviles F; Terapia Celular Aplicada al Miocardio Research Group. Ventricular arrhythmias following intracoronary bone marrow stem cell transplantation. Europace9, 1222–1223 (2007).
   PubMed Web of Science ®Google Scholar
• Monnet E, Chachques JC. Animal models of heart failure: what is new? Ann. Thorac. Surg.79, 1445–1453 (2005).
   PubMed Web of Science ®Google Scholar
• Seth S, Narang R, Bhargava B et al.; AIIMS Cardiovascular Stem Cell Study Group. Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial. J. Am. Coll. Cardiol.48, 2350–2351 (2006).
   PubMed Web of Science ®Google Scholar
• Ghodsizad A, Ruhparwar A, Marktanner R et al. Autologous transplantation of CD133+ BM-derived stem cells as a therapeutic option for dilatative cardiomyopathy. Cytotherapy8, 308–310 (2006).
   PubMed Web of Science ®Google Scholar
• Zhang N, Li J, Luo R, Jiang J, Wang JA. Bone marrow mesenchymal stem cells induce angiogenesis and attenuate the remodeling of diabetic cardiomyopathy. Exp. Clin. Endocrinol. Diabetes116, 104–111 (2008).
   PubMed Web of Science ®Google Scholar
• Vilas-Boas F, Feitosa GS, Soares MB et al. Early results of bone marrow cell transplantation to the myocardium of patients with heart failure due to Chagas disease. Arq. Bras. Cardiol.87, 159–166 (2006).
   PubMedGoogle Scholar
• Soares MB, Garcia S, Campos de Carvalho AC, Ribeiro dos Santos R. Cellular therapy in Chagas’ disease: potential applications in patients with chronic cardiomyopathy. Regen. Med.2, 257–264 (2007).
   PubMed Web of Science ®Google Scholar
• Jacob JL, Salis FV, Ruiz MA, Greco OT. Labeled stem cells transplantation to the myocardium of a patient with Chagas’ disease. Arq. Bras. Cardiol.89, e10–e11 (2007).
   Google Scholar
• Pillekamp F, Khalil M, Emmel M, Brockmeier K, Hescheler J. Stem cells in pediatric heart failure. Minerva Cardioangiol.56, 335–348 (2008).
   PubMedGoogle Scholar
• Al Kindi A, Ge Y, Shum-Tim D, Chiu RC. Cellular cardiomyoplasty: routes of cell delivery and retention. Front. Biosci.13, 2421–2434 (2008).
   PubMed Web of Science ®Google Scholar
• McCue JD, Swingen C, Feldberg T et al. The real estate of myoblast cardiac transplantation: negative remodeling is associated with location. J. Heart Lung Transplant.27, 116–123 (2008).
   PubMed Web of Science ®Google Scholar
• Chachques JC, Azarine A, Mousseaux E, El Serafi M, Cortes-Morichetti M, Carpentier A. MRI evaluation of local myocardial treatments: epicardial versus endocardial (Cell-Fix catheter) injections. J. Interv. Cardiol.20, 188–196 (2007).
   PubMedGoogle Scholar
• Chachques JC, Herreros J, Trainini J, Juffe A, Rendal E, Prosper F. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int. J. Cardiol.95(Suppl. 1), S29–S33 (2004).
   PubMed Web of Science ®Google Scholar
• Chavakis E, Urbich C, Dimmeler S. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J. Mol. Cell. Cardiol.45, 514–522 (2008).
   PubMed Web of Science ®Google Scholar
• Zhao T, Zhang D, Millard RW, Ashraf M, Wang Y. Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1α delivery and endogenous cytokine signaling. Am. J. Physiol. Heart Circ. Physiol.296, H976–H986 (2009).
   Web of Science ®Google Scholar
• Reing JE, Zhang L, Myers-Irvin J et al. Degradation products of extracellular matrix affect cell migration and proliferation. Tissue Eng. Part A.15, 605–614 (2009).
   PubMed Web of Science ®Google Scholar
• Akhyari P, Kamiya H, Haverich A, Karck M, Lichtenberg A. Myocardial tissue engineering: the extracellular matrix. Eur. J. Cardiothorac. Surg.34, 229–241 (2008).
   PubMed Web of Science ®Google Scholar
• Genovese JA, Spadaccio C, Chachques E et al. Cardiac pre-differentiation of human mesenchymal stem cells by electrostimulation. Front. Biosci.14, 2996–3002 (2009).
   Web of Science ®Google Scholar
• Prasad SM, Czepiel M, Cetinkaya C et al. Continuous hypoxic culturing maintains activation of Notch and allows long-term propagation of human embryonic stem cells without spontaneous differentiation. Cell Prolif.42, 63–74 (2009).
   PubMed Web of Science ®Google Scholar
• Chachques JC, Duarte F, Cattadori B et al. Angiogenic growth factors and/or cellular therapy for myocardial regeneration: a comparative study. J. Thorac. Cardiovasc. Surg.128, 245–253 (2004).
   PubMed Web of Science ®Google Scholar
• Kan CD, Li SH, Weisel RD, Zhang S, Li RK. Recipient age determines the cardiac functional improvement achieved by skeletal myoblast transplantation. J. Am. Coll. Cardiol.50, 1086–1092 (2007).
   PubMed Web of Science ®Google Scholar
• Gopinath SD, Rando TA. Stem cell review series: aging of the skeletal muscle stem cell niche. Aging Cell7, 590–598 (2008).
   PubMed Web of Science ®Google Scholar
• Christman KL, Lee RJ. Biomaterials for the treatment of myocardial infarction. J. Am. Coll. Cardiol.48, 907–913 (2006).
   PubMed Web of Science ®Google Scholar
• Eschenhagen T, Zimmermann WH. Engineering myocardial tissue. Circ. Res.97, 1220–1231 (2005).
   PubMed Web of Science ®Google Scholar
• Quintana L, Muiños TF, Genove E, Olmos MD, Borros S, Semino CE. Early tissue patterning recreated by mouse embryonic fibroblasts in a three-dimensional environment. Tissue Eng. Part A.15, 45–54 (2009).
   PubMed Web of Science ®Google Scholar
• van den Borne SW, Cleutjens JP, Hanemaaijer R, Creemers EE, Daemen MJ, Blankesteijn WM. Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction. Cardiovasc. Pathol.18, 37–43 (2009).
   PubMed Web of Science ®Google Scholar
• Cortes-Morichetti M, Frati G, Schussler O, Van Huyen JP, Carpentier AF, Chachques JC. Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration. Tissue Eng.13, 2681–2687 (2007).
   PubMedGoogle Scholar
• Kutschka I, Chen IY, Kofidis T et al. Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation114(1 Suppl.), I167–I173 (2006).
   PubMed Web of Science ®Google Scholar
• Chachques JC. Cardiomyoplasty: is it still a viable option in patients with end-stage heart failure? Eur. J. Cardiothorac. Surg.35, 201–203 (2009).
   PubMed Web of Science ®Google Scholar
• Coletta JE, Rosenthal N, Costa MA. Cardiac mapping and stem cell delivery for the damaged myocardium. Expert Rev. Cardiovasc. Ther.6, 1181–1190 (2008).
   PubMedGoogle Scholar
• Shafy A, Lavergne T, Latremouille C, Cortes-Morichetti M, Carpentier A, Chachques JC. Association of electrostimulation with stem cell transplantation in ischemic heart disease. J. Thorac. Cardiovasc. Surg. DOI: 10.1016/j.jtcvs.2009.02.025 (2009) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Chachques JC, Trainini JC, Lago N, Cortes-Morichetti M, Schussler O, Carpentier A. Myocardial Assistance by Grafting a New bioartificial Upgraded Myocardium (MAGNUM trial): clinical feasibility study. Ann. Thorac. Surg.85, 901–908 (2008).
   PubMed Web of Science ®Google Scholar
• Park H, Cannizzaro C, Vunjak-Novakovic G, Langer R, Vacanti CA, Farokhzad OC. Nanofabrication and microfabrication of functional materials for tissue engineering. Tissue Eng.13, 1867–1877 (2007).
   PubMedGoogle Scholar
• Genové E, Shen C, Zhang S, Semino CE. The effect of functionalized self-assembling peptide scaffolds on human aortic endothelial cell function. Biomaterials26, 3341–3351 (2005).
   PubMed Web of Science ®Google Scholar
• Schussler O, Coirault C, Louis-Tisserand M et al. Use of arginine–glycine–aspartic acid adhesion peptides coupled with a new collagen scaffold to engineer a myocardium-like tissue graft. Nat. Clin. Pract. Cardiovasc. Med.6, 240–249 (2009).
   PubMedGoogle Scholar
• Davies B, d’Udekem Y, Ukoumunne OC, Algar EM, Newgreen DF, Brizard CP. Differences in extra-cellular matrix and myocyte homeostasis between the neonatal right ventricle in hypoplastic left heart syndrome and truncus arteriosus. Eur. J. Cardiothorac. Surg.34, 738–744 (2008).
   PubMed Web of Science ®Google Scholar
• Atoui R, Shum-Tim D, Chiu RC. Myocardial regenerative therapy: immunologic basis for the potential “universal donor cells”. Ann. Thorac. Surg.86, 327–334 (2008).
   PubMed Web of Science ®Google Scholar
• Choi KD, Yu J, Smuga-Otto K et al. Hematopoietic and endothelial differentiation of human induced pluripotent. Stem Cells27, 559–567 (2009).
   PubMed Web of Science ®Google Scholar
• Yu J, Hu K, Smuga-Otto K, Tian S et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science324, 797–801 (2009).
   PubMed Web of Science ®Google Scholar
• Jones RH, Velazquez EJ, Michler RE et al.; STICH Hypothesis 2 Investigators. Coronary bypass surgery with or without surgical ventricular reconstruction. N. Engl. J. Med.360, 1705–1717 (2009).
   PubMed Web of Science ®Google Scholar
• Dib N, Dinsmore J, Lababidi Z et al. One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). JACC Cardiovasc Interv.2, 9–16 (2009).
   PubMed Web of Science ®Google Scholar
• van Ramshorst J, Bax JJ, Beeres SL et al. Intramyocardial bone marrow cell injection for chronic myocardial ischemia. A randomized controlled trial. JAMA301, 1997–2004 (2009).
   PubMed Web of Science ®Google Scholar
• Van der Laan A, Hirsch A, Nijveldt R et al. Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Neth. Heart J.16, 436–439 (2008).
   PubMed Web of Science ®Google Scholar
• Schächinger V, Erbs S, Elsässer A et al.; REPAIR-AMI Investigators. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med.355, 1210–1221 (2006).
   PubMed Web of Science ®Google Scholar
• Lunde K, Solheim S, Aakhus S et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med.355, 1199–1209 (2006).
   PubMed Web of Science ®Google Scholar
• Janssens S, Dubois C, Bogaert J et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet367, 113–121 (2006).
   PubMed Web of Science ®Google Scholar
• Wollert KC, Meyer GP, Lotz J et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet364, 141–148 (2004).
   PubMed Web of Science ®Google Scholar
• Boheler KR. The golden age of cardiomyogenic stem cells: avoiding a fool’s fate. Expert Rev. Cardiovasc. Ther.7, 1–4 (2009).
   PubMedGoogle Scholar